bioRxiv Science⌕ Search

Biology subjects

MacKay, G.

Publications and source records attributed to MacKay, G..

2 recordsLinked to original sources

Paleogenomic insight into the collapse, recovery, and management of American bison

American bison were pushed to the brink of extinction by the 20th century. This bottleneck and the fragmented nature of remnant populations pose challenges to their resilience, as does human-facilitated admixture between bison subspecies and with cattle. To contextualize current diversity, we sequenced 115 ancient and 45 modern bison genomes from across North America dating back within the last [~]20,000 years. Past bison populations were highly connected, in contrast to structured modern herds. Modern wood bison carry plains bison ancestry from 1920s translocations, while many bison lack cattle ancestry that has previously been believed to be ubiquitous. Our findings reveal the legacy of human impacts on bison in the context of modern conservation and highlight the applicability of ancient DNA for guiding wildlife restoration.

evolutionary biology↗

Cyclocreatine suppresses prostate tumorigenesis through dual effects on SAM and creatine metabolism

Prostate cancer is highly prevalent, being the second most common cause of cancer mortality in men worldwide. Applying a novel genetically engineered mouse model (GEMM) of aggressive prostate cancer driven by deficiency of PTEN and SPRY2 (Sprouty 2) tumour suppressors, we identified enhanced creatine metabolism within the phosphagen system in progressive disease. Altered creatine metabolism was validated in in vitro and in vivo prostate cancer models and in clinical cases. Upregulated creatine levels were due to increased uptake through the SLC6A8 creatine transporter and de novo synthesis, resulting in enhanced cellular basal respiration. Treatment with cyclocreatine (a creatine analogue that potently and specifically blocks the phosphagen system) dramatically reduces creatine and phosphocreatine levels. Blockade of creatine biosynthesis by cyclocreatine leads to cellular accumulation of S-adenosyl methionine (SAM), an intermediary of creatine biosynthesis, and suppresses prostate cancer growth in vitro. Furthermore, cyclocreatine treatment impairs cancer progression in our GEMM and in a xenograft liver metastasis model. Hence, by targeting the phosphagen system, cyclocreatine results in anti-tumourigenic effects from both SAM accumulation and suppressed phosphagen system.

cancer biology↗